Published in Prog Neuropsychopharmacol Biol Psychiatry on January 01, 1984
Cortisol levels during human aging predict hippocampal atrophy and memory deficits. Nat Neurosci (1998) 4.76
Circadian rhythms of melatonin and cortisol in aging. Biol Psychiatry (1989) 2.41
The Distress and Risk Assessment Method. A simple patient classification to identify distress and evaluate the risk of poor outcome. Spine (Phila Pa 1976) (1992) 2.16
Basal cortisol levels and cognitive deficits in human aging. J Neurosci (1994) 1.97
Surgery for lumbar spinal stenosis in old people. J Bone Joint Surg Br (1993) 1.87
Stress-induced declarative memory impairment in healthy elderly subjects: relationship to cortisol reactivity. J Clin Endocrinol Metab (1997) 1.56
Increased cortisol levels and impaired cognition in human aging: implication for depression and dementia in later life. Rev Neurosci (1999) 1.47
Factors in the development of severe forms of tardive dyskinesia. Am J Psychiatry (1990) 1.39
Genital infections with Chlamydia trachomatis in women attending an antenatal clinic. Br J Obstet Gynaecol (1984) 1.17
Enkephalinase: selective peptide inhibitors. Life Sci (1981) 1.12
Characterization of the anticonvulsant properties of ganaxolone (CCD 1042; 3alpha-hydroxy-3beta-methyl-5alpha-pregnan-20-one), a selective, high-affinity, steroid modulator of the gamma-aminobutyric acid(A) receptor. J Pharmacol Exp Ther (1997) 1.11
Positive allosteric modulators of the GABA(A) receptor: differential interaction of benzodiazepines and neuroactive steroids with ethanol. Psychopharmacology (Berl) (1999) 1.07
Cytokine indices in Alzheimer's temporal cortex: no changes in mature IL-1 beta or IL-1RA but increases in the associated acute phase proteins IL-6, alpha 2-macroglobulin and C-reactive protein. Brain Res (1993) 1.07
Longitudinal study of basal cortisol levels in healthy elderly subjects: evidence for subgroups. Neurobiol Aging (1996) 1.07
A controlled dose-ranging study of remoxipride and haloperidol in schizophrenia--a Canadian multicentre trial. Acta Psychiatr Scand Suppl (1990) 1.05
The use of the pain drawing as a screening measure to predict psychological distress in chronic low back pain. Spine (Phila Pa 1976) (1995) 1.04
Multiple opiate receptors: differential binding of mu, kappa and delta agonists. Neuropharmacology (1981) 1.04
Late-onset bipolar disorder. Psychiatr Clin North Am (1988) 0.99
Individual differences in hypothalamic-pituitary-adrenal activity in later life and hippocampal aging. Exp Gerontol (1995) 0.97
Anxiolytic and anticonvulsant activity of a synthetic neuroactive steroid Co 3-0593. Psychopharmacology (Berl) (1997) 0.96
Actions of D-cycloserine at the N-methyl-D-aspartate-associated glycine receptor site in vivo. Neuropharmacology (1991) 0.95
Reinforcing and discriminative stimulus effects of the neuroactive steroids pregnanolone and Co 8-7071 in rhesus monkeys. Psychopharmacology (Berl) (1999) 0.94
A five-year outcome of discharged chronic psychiatric patients. Can Psychiatr Assoc J (1972) 0.94
Increased rate of rapid axonal transport in vitamin E deficient rats. Brain Res (1975) 0.94
Nucleus basalis neuronal loss, neuritic plaques and choline acetyltransferase activity in advanced Alzheimer's disease. Neuroscience (1986) 0.94
Apomorphine-induced penile tumescence in impotent patients--preliminary findings. Prog Neuropsychopharmacol Biol Psychiatry (1987) 0.94
Apomorphine: clinical studies on erectile impotence and yawning. Prog Neuropsychopharmacol Biol Psychiatry (1989) 0.94
Diazepam in high doses is effective in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry (1982) 0.93
Kappa opiate agonists modulate the hypothalamic-pituitary-adrenocortical axis in the rat. J Pharmacol Exp Ther (1986) 0.92
Multiple opiate receptors: support for unique mu, delta and kappa sites. Neuropharmacology (1982) 0.92
Characterization of peripheral benzodiazepine type sites in a cultured murine BV-2 microglial cell line. Glia (1996) 0.91
Changes of hippocampal Met-enkephalin content after recurrent motor seizures. Nature (1980) 0.89
Circadian rhythm of plasma melatonin in endogenous depression. Prog Neuropsychopharmacol Biol Psychiatry (1984) 0.89
Alzheimer's disease may not be a spirochetosis. Neuroreport (1999) 0.89
Differential effect of unilateral and bilateral ECT. Am J Psychiatry (1970) 0.88
Spinal analgesia: comparison of the mu agonist morphine and the kappa agonist ethylketazocine. Life Sci (1981) 0.87
Changing patterns of hearing-aid use and level of support. Br J Audiol (1984) 0.87
Sigma receptors modulate the hypothalamic-pituitary-adrenal (HPA) axis centrally: evidence for a functional interaction with NMDA receptors, in vivo. Neuropharmacology (1990) 0.87
The bioavailability and pharmacokinetics of oral and depot intramuscular haloperidol in schizophrenic patients. J Clin Pharmacol (1987) 0.87
Reduced lumbar CSF somatostatin levels in Alzheimer's disease. Life Sci (1982) 0.87
Effect of sleep deprivation on dopamine receptor function in normal subjects. J Neural Transm (1981) 0.86
Kyotorphin (tyrosine-arginine): further evidence for indirect opiate receptor activation. Life Sci (1982) 0.86
Studies of a neurochemical link between depression, anxiety, and stress from [3H]imipramine and [3H]paroxetine binding on human platelets. Biol Psychiatry (1994) 0.86
Benzodiazepine interactions with central thyroid-releasing hormone binding sites: characterization and physiological significance. J Pharmacol Exp Ther (1986) 0.86
Synthesis and biological activity of 8a-phenyldecahydroquinolines as probes of PCP's binding conformation. A new PCP-like compound with increased in vivo potency. J Med Chem (1992) 0.86
Mu opiate isoreceptors: differentiation with kappa agonists. Life Sci (1983) 0.86
Opioid regulation of CNS dopaminergic pathways: a review of methodology, receptor types, regional variations and species differences. Peptides (1984) 0.86
Mu-, delta-, kappa- and epsilon-opioid receptor modulation of the hypothalamic-pituitary-adrenocortical (HPA) axis: subchronic tolerance studies of endogenous opioid peptides. Brain Res (1987) 0.85
Effects of kappa opiate agonists on neurochemical and neuroendocrine indices: evidence for kappa receptor subtypes. Life Sci (1986) 0.85
Sigma receptors modulate both A9 and A10 dopaminergic neurons in the rat brain: functional interaction with NMDA receptors. Brain Res (1990) 0.84
Modulation of the turnover rate of acetylcholine in rat brain by intraventricular injections of thyrotropin-releasing hormone, somatostatin, neurotensin and angiotensin II. J Neurochem (1978) 0.84
Multiple opiate receptor affinities of kappa and agonist/antagonist analgesics: in vivo assessment. J Pharmacol Exp Ther (1983) 0.84
The Major Depression Rating Scale (MDS). Inter-rater reliability and validity across different settings in randomized moclobemide trials. Danish University Antidepressant Group. J Affect Disord (1997) 0.84
Dopaminergic control of the septal-hippocampal cholinergic pathway. J Pharmacol Exp Ther (1979) 0.83
Comparative potencies of calcium channel antagonists and antischizophrenic drugs on central and peripheral calcium channel binding sites. J Pharm Pharmacol (1985) 0.83
Neurochemical characterization of dopaminergic effects of opipramol, a potent sigma receptor ligand, in vivo. Neuropharmacology (1990) 0.83
Actions of mu, kappa, sigma, delta and agonist/antagonist opiates on striatal dopaminergic function. J Pharmacol Exp Ther (1980) 0.83
High affinity [3H]ethylketazocine binding: evidence for specific kappa receptors. Neuropharmacology (1982) 0.82
Morphine and nigrostriatal function in the rat and mouse: the role of nigral and striatal opiate receptors. Neuropharmacology (1982) 0.81
(+) 3-[3-hydroxyphenyl-N-(1-propyl) piperidine] selectively differentiates effects of sigma ligands on neurochemical pathways modulated by sigma receptors: evidence for subtypes, in vivo. Neuropharmacology (1991) 0.81
Dopamine autoreceptors modulate the in vivo release of dopamine in the frontal, cingulate and entorhinal cortices. J Pharmacol Exp Ther (1987) 0.81
Effect of sulpiride, an atypical neuroleptic, on apomorphine-induced growth hormone secretion. Brain Res Bull (1982) 0.81
High doses of diazepam improve neuroleptic-resistant chronic schizophrenic patients. Psychopharmacology (Berl) (1983) 0.81
Substance P: evidence for spinal mediation of some behavioural effects. Neuropharmacology (1981) 0.81
Microglial cathepsin B: an immunological examination of cellular and secreted species. J Neurochem (1995) 0.80
Presence of the N-methyl-D-aspartate-associated glycine receptor agonist, D-serine, in human temporal cortex: comparison of normal, Parkinson, and Alzheimer tissues. J Neurochem (1993) 0.80
The effects of beta-phenylethylamine on tyramine and dopamine metabolism. Prog Neuropsychopharmacol Biol Psychiatry (1983) 0.80
A post-mortem comparison of the cortical cholinergic system in Alzheimer's disease and Pick's disease. J Neurol Sci (1983) 0.80
Outcome variables in presymptomatic individuals at higher risk of developing Alzheimer disease. Alzheimer Dis Assoc Disord (1996) 0.80
The Kleine-Levine syndrome--a variant? J Clin Psychiatry (1978) 0.80
Characterization of the anxiolytic properties of a novel neuroactive steroid, Co 2-6749 (GMA-839; WAY-141839; 3alpha, 21-dihydroxy-3beta-trifluoromethyl-19-nor-5beta-pregnan-20-one), a selective modulator of gamma-aminobutyric acid(A) receptors. J Pharmacol Exp Ther (2000) 0.80
Baclofen in the treatment of tardive dyskinesia. Am J Psychiatry (1978) 0.80
Benzodiazepine receptor modulation of [35S]TBPS binding to the chloride channel. Noncompetitive inhibition of classical benzodiazepines and competitive inhibition of the partial agonist, CGS 9895, by CGS 8216. Neuropharmacology (1987) 0.80
In vivo assessment of dopamine and norepinephrine release in rat neocortex: gas chromatography-mass spectrometry measurement of 3-methoxytyramine and normetanephrine. J Neurochem (1987) 0.80
Clinical and neuroendocrine studies with cholecystokinin peptides. Ann N Y Acad Sci (1985) 0.80
Homocysteic acid as a putative excitatory amino acid neurotransmitter: I. Postsynaptic characteristics at N-methyl-D-aspartate-type receptors on striatal cholinergic interneurons. J Neurochem (1988) 0.80
The metabotropic glutamate receptor antagonist L-2-amino-3-phosphonopropionic acid inhibits phosphoserine phosphatase. Eur J Pharmacol (1996) 0.80
Actions of GABAergic agents on dopamine metabolism in the nigrostriatal pathway of the rat. J Pharmacol Exp Ther (1982) 0.79
Stereoselective R-(+) enantiomer of HA-966 displays anxiolytic effects in rodents. Eur J Pharmacol (1992) 0.79
GABAergic mediation in the inhibition of hippocampal acetylcholine turnover rate elicited by delta 9-tetrahydrocannabinol. Neuropharmacology (1979) 0.79
Glucocorticoid receptor gene expression is unaltered in hippocampal neurons in Alzheimer's disease. Brain Res Mol Brain Res (1993) 0.79
Estimation of the p and m isomers of hydroxyphenylacetic acid in mouse brain by a gas chromatographic procedure: their regional distribution and the effects of some drugs. J Neurochem (1981) 0.79
Selective activation of dopaminergic pathways in the mesocortex by compounds that act at the phencyclidine (PCP) binding site: tentative evidence for PCP recognition sites not coupled to N-methyl-D-aspartate (NMDA) receptors. Neuropharmacology (1990) 0.79
Specific mu 2 opioid isoreceptor regulation of nigrostriatal neurons: in vivo evidence with naloxonazine. Neurosci Lett (1983) 0.79
Neuropharmacological characterization of 1-aminocyclopropane-1-carboxylate and 1-aminocyclobutane-1-carboxylate, ligands of the N-methyl-D-aspartate-associated glycine receptor. Neuropharmacology (1990) 0.79
The effects of muscarinic receptor blockers on the turnover rate of acetylcholine in various regions of the rat brain. Can J Physiol Pharmacol (1979) 0.79
Increase in the content of quinolinic acid in cerebrospinal fluid and frontal cortex of patients with hepatic failure. J Neurochem (1986) 0.79
An investigation of whether septal gamma-aminobutyrate-containing interneurons are involved in the reduction in the turnover rate of acetylcholine elicited by substance P and beta-endorphin in the hippocampus. Neuroscience (1979) 0.79
Axonal transport of [3H]cholesterol derived from [3H]leucine in the sciatic nerve. FEBS Lett (1980) 0.79
CSF acetylcholinesterase in dementia and in sequential samples of lumbar CSF. Neurobiol Aging (1984) 0.79
Effect of lithium on hypothalamic-pituitary dopaminergic function. Acta Psychiatr Scand (1978) 0.79
Lack of cholinergic deficit in the neocortex in Pick's disease. Prog Neuropsychopharmacol Biol Psychiatry (1983) 0.78
A prolactin action on acetylcholine metabolism in striatum, hippocampus, and thalamus. J Neurochem (1980) 0.78